Jean Luc M Lemercier Edwards Lifesciences Corp (EW) insider trading activity

Jean Luc M Lemercier is CVP, EMEACLA and JAPAC of Edwards Lifesciences Corp. Currently has a direct ownership of 184,685 shares of EW, which is worth approximately $13 Million. The most recent transaction as insider was on Jul 07, 2024, when has been sold 82 shares (Common Stock) at a price of $92.32 per share, resulting in proceeds of $7,570. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 185K

0% 3M change

6.4% 12M change

Total Value Held $13 Million

Jean-Luc M Lemercier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 07 2024	SELL Payment of exercise price or tax liability	$7,570 $92.32 p/Share	82 Reduced 0.04%	184,685 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$1,821 $86.72 p/Share	21 Reduced 0.01%	184,767 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$3,914 $85.09 p/Share	46 Reduced 0.02%	184,788 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	-	7,125 Added 3.71%	184,834 Common Stock
May 06 2024	SELL Payment of exercise price or tax liability	$22,079 $85.25 p/Share	259 Reduced 0.15%	177,709 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	4,157 Added 2.28%	177,968 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$3,147 $85.06 p/Share	37 Reduced 0.02%	173,811 Common Stock
May 01 2024	SELL Open market or private sale	$1,216,368 $84.47 p/Share	14,400 Reduced 7.65%	173,848 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$529,200 $36.75 p/Share	14,400 Added 7.11%	188,248 Common Stock
Apr 08 2024	SELL Open market or private sale	$1,331,856 $92.49 p/Share	14,400 Reduced 7.65%	173,848 Common Stock
Apr 08 2024	BUY Exercise of conversion of derivative security	$529,200 $36.75 p/Share	14,400 Added 7.11%	188,248 Common Stock
Mar 11 2024	SELL Open market or private sale	$1,320,192 $91.68 p/Share	14,400 Reduced 7.66%	173,583 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	$529,200 $36.75 p/Share	14,400 Added 7.12%	187,983 Common Stock
Jul 07 2023	SELL Payment of exercise price or tax liability	$7,327 $90.46 p/Share	81 Reduced 0.05%	173,583 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	1,575 Added 0.9%	173,664 Common Stock
May 09 2023	SELL Open market or private sale	$588,835 $88.68 p/Share	6,640 Reduced 3.72%	172,089 Common Stock
May 09 2023	BUY Exercise of conversion of derivative security	$233,728 $35.2 p/Share	6,640 Added 3.58%	178,729 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$9,228 $88.74 p/Share	104 Reduced 0.06%	172,089 Common Stock
May 07 2023	SELL Payment of exercise price or tax liability	$19,877 $88.74 p/Share	224 Reduced 0.13%	172,193 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	3,355 Added 1.91%	172,417 Common Stock
May 04 2023	SELL Payment of exercise price or tax liability	$3,347 $88.1 p/Share	38 Reduced 0.02%	169,062 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$3,248 $87.81 p/Share	37 Reduced 0.02%	169,100 Common Stock
Apr 06 2023	SELL Open market or private sale	$551,784 $83.1 p/Share	6,640 Reduced 3.78%	169,137 Common Stock
Apr 06 2023	BUY Exercise of conversion of derivative security	$233,728 $35.2 p/Share	6,640 Added 3.64%	175,777 Common Stock
Mar 08 2023	SELL Open market or private sale	$512,541 $77.19 p/Share	6,640 Reduced 3.78%	168,874 Common Stock

JML

Jean Luc M Lemercier

CVP, EMEACLA and JAPAC

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account